Stocks & Investing
Stocks and Investing
Stocks and Investing
Wed, October 6, 2021
[ Wed, Oct 06th 2021
] - WOPRAI
[ Wed, Oct 06th 2021
] - WOPRAI
[ Wed, Oct 06th 2021
] - WOPRAI
[ Wed, Oct 06th 2021
] - WOPRAI
[ Wed, Oct 06th 2021
] - WOPRAI
[ Wed, Oct 06th 2021
] - WOPRAI
[ Wed, Oct 06th 2021
] - WOPRAI
[ Wed, Oct 06th 2021
] - WOPRAI
Tue, October 5, 2021
[ Tue, Oct 05th 2021
] - WOPRAI
[ Tue, Oct 05th 2021
] - WOPRAI
[ Tue, Oct 05th 2021
] - WOPRAI
[ Tue, Oct 05th 2021
] - WOPRAI
[ Tue, Oct 05th 2021
] - WOPRAI
[ Tue, Oct 05th 2021
] - WOPRAI
[ Tue, Oct 05th 2021
] - WOPRAI
[ Tue, Oct 05th 2021
] - WOPRAI
[ Tue, Oct 05th 2021
] - WOPRAI
[ Tue, Oct 05th 2021
] - WOPRAI
[ Tue, Oct 05th 2021
] - WOPRAI
[ Tue, Oct 05th 2021
] - WOPRAI
[ Tue, Oct 05th 2021
] - WOPRAI
[ Tue, Oct 05th 2021
] - WOPRAI
[ Tue, Oct 05th 2021
] - WOPRAI
[ Tue, Oct 05th 2021
] - WOPRAI
[ Tue, Oct 05th 2021
] - WOPRAI
[ Tue, Oct 05th 2021
] - WOPRAI
[ Tue, Oct 05th 2021
] - WOPRAI
[ Tue, Oct 05th 2021
] - WOPRAI
Matthew Harrison Downgraded (AVIR) to Hold and Held Target at $55 on, Oct 5th, 2021
Matthew Harrison of Morgan Stanley, Downgraded "Atea Pharmaceuticals, Inc." (AVIR) to Hold and Held Target at $55 on, Oct 5th, 2021.
Matthew has made no other calls on AVIR in the last 4 months.
There is 1 other peer that has a rating on AVIR. Out of the 1 peers that are also analyzing AVIR, 0 agree with Matthew's Rating of Hold.
This is the rating of the analyst that currently disagrees with Matthew
- Roanna Ruiz of "SVB Leerink" Initiated at Buy and Held Target at $60 on, Thursday, September 9th, 2021
